Oculis Holding AG
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $7.39
- 52-Week Range
- $6.78 – $34.48
- Market Cap
- $414.52M
- P/E (TTM)
- —
- EPS (TTM)
- -1.69
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 1.79
- PEG Ratio
- —
- Return on Equity
- -47.49%
- Return on Assets
- -27.98%
- Gross Margin
- 0.00%
- Operating Margin
- -9558.91%
- Profit Margin
- 0.00%
- Current Ratio
- 10.41
- Debt/Equity
- 0.01
- Total Debt
- $2.79M
- Free Cash Flow
- —
- Revenue Growth
- -97.10%
- Earnings Growth
- —
- Enterprise Value
- $241.71M
Market Snapshot
About
Oculis Holding AG is an ophthalmic biopharmaceutical company developing innovative treatments for eye diseases including diabetic macular edema and dry eye disease.